Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Visteon Slips To Loss In Q1 - Quick Facts

Visteon Corp. (VC: Quote) reported net loss attributable to the company of $29 million or $0.56 per share for the first quarter versus net income of $39 million or $0.75 per share last year.

Loss from continuing operations for the quarter was $14 million or $0.62 per share compared to income from continuing operations of $52 million or $0.67 per share a year ago.

Quarterly sales fell year-over-year to $1.72 billion from $1.85 billion.

Analysts polled by Thomson Reuters expected the company to earn $0.65 per share on revenues of $1.80 billion for the quarter. Analysts' estimates typically exclude special items.

Going ahead, the company currently expects full-year 2012 product sales in the range of $6.6 billion to $7.0 billion and adjusted EBITDA in the range of $620 million to $660 million.

Analysts anticipate revenues of $7.33 billion for the year.

Click here to receive FREE breaking news email alerts for Visteon Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Citing extreme fluctuation of the ruble, Apple Inc. (AAPL) has reportedly discontinued its online sales of products in Russia. Despite efforts of the Russian central bank, the ruble has been spiraling downward, with oil prices plunging to historic levels. The ruble shed around 19 percent on Wednesday.... General Motors said it has halted the delivery of cars to dealerships in Russia as it strives to overcome the business risks stemming from the collapse of the ruble. The terrorists, in this case, have won. In an unprecedented move that may have far-reaching cultural and political effects, Sony Pictures has scrapped the release of "The Interview." The plot of the film, a comedy starring Seth Rogen and James Franco, revolves around a fictional assassination...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.